Riskpilot← Back to searchSign inGet full accessSAVINA AS
ASActiveOrg 922389284Mogens Thorsens Gate 10, 0264 OsloDental practice care activities · NACE 8623Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
-2671% vs 2023
Equity ratio
68.2%
Financial strength
Net profit 2024
NOK -593K
-6987% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -593K | -2671% |
| Net profit | NOK -593K | -6987% |
| Total assets | NOK 2,3M | +95% |
| Equity | NOK 1,5M | +36% |
| Employees | 0 | — |
Legal name
SAVINA AS
Org number
922389284
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
23. april 2019
Share capital
NOK 1 331 196
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i og drifte tannlegesentre og tilhørende virksomhet i norge.
Address
Mogens Thorsens Gate 10, 0264 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −535 |
| EBITDA | −3 | −13 | −12 | −21 | −593 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −13 | −12 | −21 | −593 |
| Net financials | 0 | −20 | −60 | 30 | −0 |
| Profit before tax | −3 | −33 | −72 | 9 | −593 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −33 | −72 | 9 | −593 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 235 | 2 002 | 1 130 | 1 162 | 2 269 |
| Equity | 1 235 | 1 202 | 1 130 | 1 139 | 1 547 |
| Long-term debt | 0 | 0 | 0 | 0 | 359 |
| Short-term debt | 0 | 800 | 0 | 24 | 362 |
| Total debt | 0 | 800 | 0 | 24 | 721 |
EBITDA margin
-59297700.0%
This company
15.8%
Market median
-375301999% vs market
20202024
Equity ratio
68.2%
This company
38.2%
Market median
+79% vs market
20202024
Return on equity
-38.3%
This company
18.4%
Market median
-308% vs market
20202024
Net profit margin
-59321400.0%
This company
8.1%
Market median
-732363063% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RE Chief Executive Officer | Chief Executive Officer | 2024 |
DV Deputy Member | Deputy Member | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 | |
| Company | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Spesialist Klinikken As
SAVINA AS Board members of SAVINA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Richard Engen | Chief Executive Officer | 0 companies |
| Daliborka Vujadin Kjellsen | Deputy Member | 0 companies |
| Kristian Kjellsen | Chairman | 0 companies |